-
1261“…BACKGROUND: Neoadjuvant therapies (neoTx) have revolutionized the treatment of borderline resectable (BR) and locally advanced (LA) pancreatic cancer (PCa) by significantly increasing the rate of R0 resections, which remains the only curative strategy for these patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1262por Kouzy, Ramez, Abi Jaoude, Joseph, Lin, Daniel, Nguyen, Nicholas D., El Alam, Molly B., Ludmir, Ethan B., Taniguchi, Cullen M.“…In this review, we describe the landscape of different PRO instruments pertaining to pancreatic cancer, with specific emphasis on PRO findings related to pancreatic cancer patients receiving radiotherapy (RT). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1263“…SIMPLE SUMMARY: Pancreatic Cancer is a deadly disease, with a dismal prognosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1264por Yousaf, Muhammad Nadeem, Ehsan, Hamid, Wahab, Ahsan, Muneeb, Ahmad, Chaudhary, Fizah S, Williams, Richard, Haas, Christopher J“…Pancreatic cancer is the leading cause of cancer-related morbidity and mortality with an overall five-year survival of less than 9% in the United States. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1265por Farias, Albert J, Wu, Anna H, Porcel, Jacqueline, Marchand, Loïc Le, Wilkens, Lynne R, Monroe, Kristine R, Maskarinec, Gertraud, Pandol, Stephen J, Setiawan, Veronica Wendy“…BACKGROUND: People with diabetes are at an increased risk of developing pancreatic cancer. However, it is unclear whether diabetes-related complications are associated with risk of pancreatic cancer. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1266por Glicksman, Rachel M, Chung, Hans, Myrehaug, Sten, Erler, Darby, Korol, Renee, Karotki, Aliaksandr, Taggar, Aman, Ung, Yee C“…Introduction Despite treatment advances, the prognosis of locally advanced pancreatic cancer is poor. Treatment remains varied and includes systemic and radiotherapy (RT). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1267por Zhou, Shuyi, Yan, Yuanliang, Chen, Xi, Zeng, Shuangshuang, Wei, Jie, Wang, Xiang, Gong, Zhicheng, Xu, Zhijie“…The purpose of this study was to identify a vital gene signature that has prognostic value for pancreatic cancer based on gene expression datasets from the Cancer Genome Atlas and Gene Expression Omnibus. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1268por Alcalá, Sonia, Mayoral-Varo, Víctor, Ruiz-Cañas, Laura, López-Gil, Juan Carlos, Heeschen, Christopher, Martín-Pérez, Jorge, Sainz, Bruno“…PDAC is characterized by its high lethality (5-year survival of rate of <10%), invasiveness, and chemoresistance, all of which have been shown to be due to the presence of pancreatic cancer stem cells (PaCSCs) within the tumor. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1269“…Compared with pancreatitis and pancreatic cancer, DEP and EPD yielded lower but more steeply increasing projected incidence rates and YLLs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1270por Iwai, Naoto, Okuda, Takashi, Sakagami, Junichi, Harada, Taishi, Ohara, Tomoya, Taniguchi, Masashi, Sakai, Hiroaki, Oka, Kohei, Hara, Tasuku, Tsuji, Toshifumi, Komaki, Toshiyuki, Kagawa, Keizo, Yasuda, Hiroaki, Naito, Yuji, Itoh, Yoshito“…Inflammation-based prognostic indicators have been developed to predict the prognosis in patients with pancreatic cancer. However, prognostic indices have not been established in patients with unresectable pancreatic cancer, including those without indication for chemotherapy at diagnosis. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1271por Prades, Joan, Arnold, Dirk, Brunner, Thomas, Cardone, Antonella, Carrato, Alfredo, Coll-Ortega, Cristina, De Luze, Samuel, Garel, Pascal, Goossens, Maria E, Grilli, Roberto, Harris, Meggan, Louagie, Marleen, Malats, Núria, Minicozzi, Pamela, Partelli, Stefano, Pastorekova, Silvia, Petrulionis, Marius, Price, Richard, Sclafani, Francesco, Smolkova, Bozena, Borras, Josep M“…Pancreatic cancer is one of the most lethal tumours, and it is the fourth cause of cancer death in Europe. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1272por Kobayashi, Tetsuo, Tanaka, Kosuke, Mashima, Yu, Shoda, Ayano, Tokuda, Mio, Itoh, HiroshiEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1273por Lee, Seung Yup, Pakela, Julia M., Na, Kyounghwan, Shi, Jiaqi, McKenna, Barbara J., Simeone, Diane M., Yoon, Euisik, Scheiman, James M., Mycek, Mary-Ann“…Pancreatic cancer is one of the deadliest cancers, with a 5-year survival rate of <10%. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1274por Khomiak, Andrii, Brunner, Marius, Kordes, Maximilian, Lindblad, Stina, Miksch, Rainer Christoph, Öhlund, Daniel, Regel, Ivonne“…In the review, we summarized current investigations on using novel protein markers, cell-free DNA, metabolome compounds, immune and stroma signatures and microbiome compositions as biomarkers for pancreatic cancer. Our comprehensive overview shows that although there are new promising biomarkers, CA 19-9 remains currently the only regularly used and validated biomarker for pancreatic cancer in clinical routine. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1275por Téoule, Patrick, Rasbach, Erik, Oweira, Hani, Otto, Mirko, Rahbari, Nuh N., Reissfelder, Christoph, Rückert, Felix, Birgin, EmrullahEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1276“…While many vectors have been explored, few show promise as treatment for pancreatic cancer, and fewer still have progressed to clinical trial evaluation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1277por Deutsch, O., Haviv, Y., Krief, G., Keshet, N., Westreich, R., Stemmer, S. M., Zaks, B., Navat, S. P., Yanko, R., Lahav, O., Aframian, D. J., Palmon, A.“…The 80% mortality rate of pancreatic-cancer (PC) makes early diagnosis a challenge. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1278por Nguyen, Lily, Schilling, Daniela, Dobiasch, Sophie, Raulefs, Susanne, Santiago Franco, Marina, Buschmann, Dominik, Pfaffl, Michael W., Schmid, Thomas E., Combs, Stephanie E.“…SIMPLE SUMMARY: Pancreatic cancer is an aggressive disease with a high mortality rate. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1279por Turpin, Anthony, el Amrani, Mehdi, Bachet, Jean-Baptiste, Pietrasz, Daniel, Schwarz, Lilian, Hammel, Pascal“…SIMPLE SUMMARY: In operated pancreatic cancer patients who are able to begin treatment within 3 months after surgery, adjuvant chemotherapy is currently used to limit disease recurrence but questions remain for the clinician. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1280“…Pancreatic cancer is now increasingly observed in young patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto